NMN (Nicotinamide Mononucleotide) vs Berberine (Liposomal)

Side-by-side comparison of evidence grade, dosage, safety, and stacking compatibility.

Combined: Caution ⚠Both activate AMPK through different pathways. Acceptable to combine but avoid i

Overview

A nucleotide precursor that replenishes cellular NAD+ levels, which decline significantly with age. Among the most-researched longevity compounds with human clinical trial data.

Summary

An isoquinoline alkaloid that activates AMPK - the same pathway as metformin. Liposomal delivery overcomes berberine's poor bioavailability, making it one of the most powerful natural interventions for glucose management, lipid control, and metabolic longevity. Often called 'nature's metformin'.
NAD+ Precursor

Category

Metabolic / AMPK Activator
B

Evidence Grade

A = strongest

B wins
A
Tier A — Proven

Safety Tier

A = safest

A wins
Tier B — Moderate

Dosage

500 mg/day

Typical Dose

1000 mg/day
250–1000 mg

Low / High

500–1500 mg
Morning, fasted or with a light breakfast

Timing

With meals, 2-3x daily. Liposomal form: 500mg once daily with largest meal.
5 days on, 2 days off (optional cycling protocol)

Cycling

8-12 weeks on, 4 weeks off to prevent gut microbiome adaptation

Goals & Use Cases

longevityenergycellular-repair

Primary Goals

metabolic-healthlongevitycardiovascular
Shared goals:longevity

Safety Profile

  • Active cancer treatment (consult oncologist first)
  • Pregnancy or breastfeeding (insufficient safety data)

Contraindications

fewer = safer

A wins
  • Pregnancy - may stimulate uterine contractions
  • Newborns and infants - can displace bilirubin
  • Hypoglycaemia risk when combined with diabetes medications

Regulatory Status

✓ Legal

Legal (US)

✓ Legal
✓ Legal

Legal (EU)

✓ Legal

Can you take NMN (Nicotinamide Mononucleotide) and Berberine (Liposomal) together?

Caution ⚠

Both activate AMPK through different pathways. Acceptable to combine but avoid if also on metformin. Monitor glucose.